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ABSTRACT 
THE DESIGN AND PHYSICAL PROPERTIES OF AN OPTIMIZED CHITOSAN 
HYDROGEL FOR POTENTIAL USE IN ENDODONTICS 
 
 
Hunter R. Housley, D.M.D. 
 
Marquette University, 2019 
 
 
 Introduction: The aim of this study was to synthesize an optimized 
chitosan/carbon dot hydrogel and measure its effects on the proliferation of dental pulp 
stem cells. 
  
Methods: 1.5% w/v chitosan hydrogel samples were fabricated with 300 mg/ml 
aqueous β-glycerol phosphate (β-GP) to create an optimized chitosan with a gelation 
onset temperature below 37°C. Spermidine-functionalized carbon dots (CDs) were added 
to test groups in concentrations of 25 µg/ml and 50 µg/ml. Complex shear viscosity of the 
prepared hydrogel samples was evaluated with a Kinexus pro+ shear rheometer (Malvern 
Panalytical). Samples were evaluated for cellular proliferation with dental pulp stem cells 
at days 1, 2, 5, and 14 using PrestoBlue and a Synergy HTX microplate reader (BioTek). 
Proliferation results were compared to a separate test groups with calcium hydroxide 
under the same test parameters. 
 
Results: The optimized chitosan hydrogel samples had a gelation onset 
temperature of 34.6°C, which was not appreciably increased with the addition of CDs 
(34.7°C). All experimental chitosan hydrogels demonstrated superior cellular 
proliferation when compared to calcium hydroxide paste. 
  
Conclusions: Chitosan/CD hydrogels may be a promising medicament for 
endodontic use and a viable alternative to either Ca(OH)2 or TAP in regenerative 
endodontic cases. The CD structure contains surface characteristics that are open to 
customization for individual therapeutic needs. This hydrogel is thermally responsive and 
becomes a solid gel when administered at human body temperature. Further studies are 
warranted to determine its antibacterial properties, as well as other factors to understand 
how it may interact in the root canal space. 
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INTRODUCTION 
 
 Among the medical and dental fields, a wide variety of biomaterials have been 
designed to improve treatment predictability and patient outcomes. When materials are 
engineered specifically for the body, one must consider all of the following as high 
priorities: safety, efficacy, and cost. It is often particularly challenging to meet each of 
these goals with the same biomaterial. A product may be safe and effective, but 
expensive; in contrast, a different product may be effective and low-cost, but unsafe. It is 
the pursuit of ideal materials that fuels innovation within healthcare. 
Endodontics is the dental specialty devoted to maintaining health within the 
dental pulp, as well as treating diseases and/or injuries that occur within the tooth. 
Throughout the era of modern endodontics, materials used for the purpose of canal 
disinfection have largely remained the same. Canal disinfection with 5.25% sodium 
hypochlorite and interappointment calcium hydroxide, when indicated, have become the 
gold standard. These materials, however, are cytotoxic and necessitate careful use. 
Among the recently developed biomaterials, it is time to explore alternatives to common 
disinfectants in endodontics. 
This study focuses specifically on the development of an optimized chitosan 
hydrogel, using spermidine-functionalized carbon dot (CD) nanoparticles as antibacterial 
additives. While currently in development, this material possesses promising attributes 
for potential use as an endodontic medicament. The following literature review and 
subsequent study will provide background knowledge of endodontic treatment, 
medicaments, and the potential role of this new material in clinical practice.  
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LITERATURE REVIEW 
 
 
Goals of Modern Endodontics 
 
 
As shown by the classic works of Kakehashi and Moller, bacteria within the 
dental pulp are the primary cause of apical periodontitis (1, 2). While not always painful, 
these diseases are commonly a result of complex biofilm invasion into the pulp tissue, 
which proliferates without proper dental intervention. As disease progression continues, 
biofilms become more established and increasingly resilient (3). Root canal therapy 
(RCT) is a commonly prescribed procedure with the fundamental aim to remove biofilm 
within the canal space and resolve dental infections (4). When performed to the 
appropriate standard of care, RCT has high success rates (5). This treatment is carried out 
by accessing the canal space, physically and chemically debriding the canal walls, and 
filling the space with material to provide a hermetic seal. While several factors contribute 
to the overall success of RCT, proper disinfection is paramount. It is commonly believed 
that residual biofilm is responsible for most endodontic failures (6, 7). 
Regenerative Endodontics 
 
 
Pulpal regeneration is a newer concept in endodontic therapy, based upon 
principles of tissue engineering. Just as in medicine, tissue engineering within the tooth 
requires an interplay of scaffolds, growth factors, and stem cells (8). Pulpal regeneration 
is not possible in all cases requiring RCT due to the lack of blood flow or stem cell 
availability. These techniques are reserved for necrotic teeth with apices larger than 1mm 
(9). When done correctly, the treatment can reestablish vascularized connective tissue 
within the tooth canal space and aid in continued root development. Since the newly 
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formed tissue lacks resemblance of healthy pulp, the term regeneration continues to be a 
topic of debate (10). This procedure is also referred to as revascularization, revitalization 
(11), or maturogenesis (12) among various experts.  
There are often two or more steps involved in regenerative endodontics (13). The 
goal of the initial appointment is to access and adequately disinfect the canal space. Due 
to the high cytotoxicity of full-strength sodium hypochlorite, it is recommended to 
disinfect the canal with a 1.5% diluted concentration (14). At the end of the first 
appointment, either a calcium hydroxide (Ca(OH)2) or triple antibiotic paste (TAP) 
medicament is placed. The goal of the second appointment is to remove the medicament, 
irrigate with ethylenediaminetetraacetic acid (EDTA) to release dentinal growth factors, 
and stimulate apical bleeding to create a scaffold. This process also facilitates stem cell 
migration (15), which is critical in the success of the procedure. A barrier is placed over 
the blood clot scaffold using mineral trioxide aggregate (MTA) or bioceramic putty and 
the tooth is permanently restored with resin or amalgam (16). 
Both root canal therapy and pulpal regeneration require adequate disinfection for 
optimal results. In the case of regeneration, maintaining cell viability is also fundamental 
to success of the procedure. Using the currently available medicaments, disinfection is 
proportional to cytotoxicity—as the concentration of the disinfectant increases, 
cytotoxicity also increases. Thus, it desirable to understand the properties of currently 
available medicaments and test newer materials that carry an inherently lower cytotoxic 
effect.  
 
 
4 
Current Medicaments and their Use in Endodontics 
 
 
 According to the American Academy of Endodontists (AAE) Glossary of 
Endodontic Terms, medicaments are “interappointment agents used for palliative or 
antimicrobial purposes” (17). Though there continues to be a lack of consensus regarding 
single-visit versus multiple-visit therapy (18-21), medicaments still have their place in 
endodontics when additional measures for canal disinfection are indicated. The most 
commonly used medicaments are Ca(OH)2 (with or without iodoform) and TAP. It is 
important to understand the characteristics of these materials in order to determine their 
best use in patient care. 
First introduced by Hermann in the 1920’s (22), Ca(OH)2 is the most frequently 
utilized medicament in endodontics. It is strongly alkaline, with an approximate pH of 
12.5 (23). When injected into the canal space, it separates into calcium and hydroxyl ions 
to increase the local pH (24). As long as the high pH is sustained, Ca(OH)2 aids in 
bacterial destruction (23). Additionally, it has been shown to neutralize osteoclastic 
activity (25, 26), dissolve necrotic tissue (27), and break down bacterial 
lipopolysaccharides (25). Paula-Silva also found that interappointment Ca(OH)2 lowered 
bacterial prevalence, decreased matrixmetalloproteinase (MMP) expression, and reduced 
inflammatory cell infiltrate (21).  
Despite the many purported benefits of Ca(OH)2, its efficacy and biocompatibility 
are unclear. Many sources conclude that Ca(OH)2 is ineffective as a medicament (28-30). 
In fact, some sources claim that it exhibits virtually no antimicrobial effect whatsoever 
(31-34). Candida albicans and Enterococcus faecalis, pathogens commonly associated 
with endodontic failures, are notably resistant to Ca(OH)2 (35-38). 
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There is also some evidence that extrusion of Ca(OH)2 may lead to delayed 
healing and apical tissue necrosis (39, 40). Due to its high pH, Ca(OH)2 creates a zone of 
necrosis immediately adjacent to surrounding tissue and may disrupt cells that could 
differentiate into new pulp (41, 42). The work of Badr demonstrated that Ca(OH)2 is 
highly toxic to stem cells (43), but other sources contradict this finding (44, 45). Based 
off animal studies, Andreasen concluded that prolonged use of Ca(OH)2 increases the risk 
of root fracture (46). Thus, it is advisable to minimize the overall duration of the 
medicament use. Regardless of these risks, Ca(OH)2 remains the current medicament of 
choice in endodontics. 
TAP is an alternative endodontic medicament developed by Hoshino and 
colleagues (47). Traditionally consisting of metronidazole, ciprofloxacin, and 
minocycline, TAP uses a mixture of antibiotics to combat the broad spectrum of 
endodontic pathogens. The antibiotic paste has been shown to be more effective than 
Ca(OH)2 against E. faecalis (48) and demonstrates promising outcomes when used in 
regenerative endodontics (49). TAP penetrates deep into the dentinal tubules and has a 
sustained antibacterial effect. This attribute leads to effective disinfection but presents a 
challenge in removal of the antibiotic (14). Berkhoff found that after various techniques 
of copious irrigation, 80% of the antibiotic remained tightly bound to dentin (50). In the 
same study, less than 15% of Ca(OH)2 persisted along the canal wall (50). The inability 
to effectively remove TAP is thought to be an undesirable trait due to the medicament’s 
cytotoxicity to stem cells (51, 52). TAP also has a short shelf life, tendency to stain 
dentin (53), and potential for allergic reactions, thus making it less appealing for use as a 
medicament. 
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It is clear that both Ca(OH)2 and TAP have shortcomings when used as 
medicaments. For this purpose, disinfection by some other means continues to be 
investigated. 
Polymers as an Alternative Medicament Vehicle 
 
 
There are various alternatives to be explored as intracanal medicaments. Polymers 
are long molecules consisting of repeating sequences of covalently bonded chains. 
Among this family of materials, there are many choices with potential use in medicine 
and tissue engineering. Some polymers are naturally occurring, such as collagen, gelatin, 
chitin/chitosan, hyaluronic acid, and alginate. Natural polymers are inherently 
biocompatible and biodegradable (54, 55), which are ideal material characteristics for the 
endodontic uses previously described. Other polymers are made synthetically such as: 
polyethylene glycol (PEG), polyglycolic acid (PGA), and polycaprolactone (PCL). 
Though effective in various applications, these synthetic polymers may not be as ideal for 
endodontic use.  
Due to its high water solubility and imbibition, PEG may not remain stable when 
left as a medicament in the canal space (56). PGA may also be an inappropriate material 
choice due to its acidic degradation and evidence of inducing inflammation in vivo (57). 
Though PCL is biocompatible, its use in endodontics has been a historic failure. Resilon, 
a product comprised of PCL, was widely touted as a replacement for gutta percha as an 
obturation material. After a few years of use, Resilon began to show a much higher 
failure rate. In a recent study, Barborka et al found that Resilon-treated teeth failed 5.7 
times more frequently than those treated with gutta percha (58). Due to its history, the use 
of PCL as a carrier for intracanal medicament would be highly scrutinized. 
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Chitosan Hydrogels 
 Though several natural polymers have attributes that can be harnessed for 
endodontic use, in terms of disinfection and biocompatibility, none seem as inherently 
ideal as chitosan. Chitosan is produced through the deacetylation of chitin, a naturally 
available polymer found in the exoskeleton of crustaceans and in fungi cell walls. 
Naturally toxic to fungi, bacteria, and parasites, chitosan is biocompatible and minimally 
toxic to mammalian cells (59). When acting as an antimicrobial, chitosan binds to 
negatively charged cell surfaces to increase bacterial cell wall permeability and cause 
intracellular leakage (60). Chitosan is biodegradable and comes in several forms for use 
in regenerative medicine such as: hydrogels, fibers, sponges, and 3-dimensionally printed 
scaffolds (61-63).  
For purposes of injectability, chitosan in hydrogel form is a logical choice for a 
potential medicament in endodontics. Hao et al developed a temperature-responsive 
hydrogel that showed promising healing properties within cartilaginous joint defects (64). 
Harnessing the properties of such a material for dental use would allow for the hydrogel 
to be injected into the endodontic canal space in a more aqueous sol phase. After reaching 
an optimized physiologic gelation temperature, the biomaterial could undergo a phase 
change into a solidified gel phase to enhance stability. When prepared at a low pH, 
chitosan hydrogels are also thermally reversible (65). This property would theoretically 
allow for easy removal within the root canal space by converting the hydrogel back to the 
aqueous sol phase.  
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Application of Nanomaterials 
 
 
One major concern with antimicrobial drugs is the potential for developing drug 
resistance. Over the years of prescribing drugs to combat bacterial pathogens, stronger 
drug-resistant strains have shown an adaptive capacity to counteract antibiotic efficacy. 
These tenacious strains are prevalent and continue to present a medical challenge. As 
previously discussed, drug resistance has already been noted with the use of Ca(OH)2 in 
endodontics (36). Nanomaterials appear to be a promising solution to enhance microbial 
effectiveness and decrease the potential for resistance. These microscopic particles carry 
many advantages because of their extremely large surface area. Due to their ability to 
disrupt multiple biologic pathways among microbes, experts suggest bacterial resistance 
to nanomaterials is unlikely (66).  
 Carbon dots (CDs) are a nanomaterial with fascinating potential in medical 
applications. CDs are generally defined as small carbon nanoparticles (smaller than 
10nm) that contain various surface passivation schemes (67). Many techniques have been 
used to synthesize CDs, including chemical ablation (68-71), laser ablation (72-75), 
electrochemical carbonization (76-78), microwave irradiation (79-81), and 
hydrothermal/solvothermal treatment (82-86). Depending on the method of synthesis, 
particle size can either be highly specific or variable (87). CDs are relatively cost-
effective and easy to synthesize, making them readily available (88). 
A key characteristic to CDs effectiveness is the small particle size. Due to their 
microscopic nature, CDs drastically enhance the surface area to interact with the bacterial 
cell surface (59). When combined with other antibacterial reagents, CDs are shown to 
have a synergistic bactericidal effect (89, 90). The works of Omidi et al showed that a 
9 
carbon dot/chitosan nanocomposite was highly effective against S. aureus in a wound 
healing application (91).  
It has been shown that CDs exhibit good water solubility, low toxicity, and high 
stability (92). CDs are inherently photoluminescent and such properties can be enhanced 
via chemical doping with elements such as nitrogen (93, 94), sulfur (95, 96), or 
phosphorus (97). As a fluorescent nanomaterial with excellent biocompatibility, CDs 
have shown great promise for fluorescent bioimaging (87). CDs have an abundance of 
oxygen-containing groups, providing a means for surface functionalization via covalent 
bonding (84, 98). This allows for vast customization of the CDs surface to alter and 
improve their properties for any given need. 
Considering the body of literature surrounding these new materials and the 
challenges of root canal disinfection, this study was constructed to create an injectable 
CD/chitosan hydrogel that will encourage greater stem cell proliferation than Ca(OH)2 
paste. More specifically, the study was completed with the following aims: 
1. To design a thermally responsive chitosan hydrogel with a gelation onset 
temperature below 37°C 
 
2. To add CD nanoparticles to the hydrogel in order to enhance hydrogel 
qualities 
 
3. To evaluate this novel hydrogel for its effect on dental pulp stem cell 
proliferation, in comparison with calcium hydroxide paste 
 
 
  
10 
EXPERIMENTAL DETAILS 
 
 
Materials 
 
 The materials used throughout this study can be referenced in Table 1. 
 
 
Table 1: Experimental materials 
 
 
 
 
Equipment 
 
 The equipment used throughout this study can be referenced in Table 2. 
 
 
Table 2: Experimental equipment 
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Fabrication 
 
A preliminary study was performed to determine the relative concentrations 
needed to create a chitosan hydrogel with a gelation onset temperature (𝑇𝑜𝑛𝑠𝑒𝑡) slightly 
lower than the average human body temperature, between 30°C and 37°C. A 3% 
weight/volume (w/v) chitosan solution was made by mixing 3 g of medium molecular 
weight chitosan in 100 ml deionized water, while adding 1.3 ml of 10% acetic acid 
dropwise (Figure 1). Various concentrations of aqueous β-glycerol phosphate (β-GP) 
were prepared and combined in a 1:1 ratio with the chitosan gel, using a vortex mixer and 
centrifugation (Figure 2). The samples tested in this initial study consisted of 1.5% w/v 
chitosan with β-GP concentrations of 175, 250, and 300 mg/ml. 
 
 
 
Figure 1: 3% w/v chitosan hydrogel prior 
to the addition of aqueous β-GP 
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Figure 2: 1.5% w/v chitosan hydrogel samples fabricated for the preliminary study to 
determine the necessary concentrations of β-GP to reach an ideal 𝑻𝒐𝒏𝒔𝒆𝒕 (not pictured: 
300 mg/ml β-GP). 
 
These samples were tested with a Kinexus pro+ shear rheometer (Malvern 
Panalytical) (Figure 3). Gel samples were independently loaded onto the rheometer’s 
thermoregulated platform and complex shear viscosity was measured as the temperature 
increased. Samples were evaluated using both single-frequency and multiple-frequency 
rheometry parameters. Since single-frequency settings yielded comparable results and 
allowed for more streamlined testing, this approach was used as the primary method for 
evaluating the 𝑇𝑜𝑛𝑠𝑒𝑡 throughout the later stages of this study. 
The recorded data points were plotted to determine the 𝑇𝑜𝑛𝑠𝑒𝑡 of each sample. It 
was determined that 1.5% w/v chitosan with 300 mg/ml β-GP contained an ideal gelation 
temperature, which will be discussed later in further detail. This sample concentration 
was used throughout the remainder of the experiment and will hereafter be referred to as 
“optimized chitosan.”  
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Figure 3: Loading hydrogel samples onto the rheometer 
 
CDs were then synthesized with a simple heating method. This was done by 
placing 2 g of ammonium citrate powder in a beaker and heating the substance in an oven 
at 180°C for two hours, thus creating a dark brown residue. The resulting CDs were 
cooled to room temperature and ground into a fine powder, then stored for later use.  
Functionalization 
 
 
In order to functionalize the CDs with spermidine, 0.025 g of CDs powder was 
added to 1 ml of 0.1 M spermidine solution in a beaker. This mixture was heated to 
260°C for two hours and subsequently cooled to room temperature (Figure 4). The 
remaining residue was dissolved in 5 ml of deionized water, then centrifuged for one 
hour at 6000 rpm to separate larger particles. Finer CDs were removed with the 
supernatant and poured into a dialysis bag (MWCO~1.0 Kda) for further filtration. 
14 
Dialysis was performed for five hours with water replacement every hour and the 
resulting carbon dot powder was stored at 4°C for later use.  
 
 
 
 
 
 
 
 
 
In order to form a homogenous mixture of CDs within the optimized chitosan, the 
hydrogel had to be refabricated. Slightly modifying the steps previously outlined in gel 
synthesis, spermidine-functionalized CDs were mixed into aqueous β-GP, then added to 
the chitosan (Figure 5). Samples were combined in a test tube and agitated by Vortex 
mixer, ultrasonic bath, and centrifugation. The final compositions of the experimental 
gels are as follows: 
1) 1.5% w/v chitosan, 300mg/ml β-GP (optimized chitosan) 
2) 1.5% w/v chitosan, 300mg/ml β-GP, 25 µg/ml CDs 
3) 1.5% w/v chitosan, 300mg/ml β-GP, 50 µg/ml CDs 
These resulting hydrogels were subjected to single-frequency rheometry, as previously 
described, to evaluate 𝑇𝑜𝑛𝑠𝑒𝑡. 
  
Figure 4: Synthesis process for spermidine-functionalized CDs via solid state pyrolysis 
15 
 
Figure 5: Addition of aqueous β-GP and CDs to chitosan gel. Pictured from left to 
right: 600 mg/ml β-GP, 600 mg/ml β-GP with 50 µg/ml CDs, 600 mg/ml β-GP with 100  
µg/ml, 1.5% w/v chitosan with 300 mg/ml β-GP and 50 µg/ml CDs. 
 
Cell Proliferation 
 
De-identified dental pulp stem cells (DPSCs) were acquired from the research 
laboratory at the Marquette University School of Dentistry for testing cell proliferation of 
the experimental hydrogels. These cells were previously harvested from the pulp tissue of 
extracted human third molar teeth and were kept viable for research purposes. A growth 
media consisting of DMEM, 15% FBS, 1% L-glutamine, and 1% penicillin/streptomycin 
antibiotic was prepared. Cells were added to the media and incubated until the 3rd 
passage. They were visualized and counted using an EVOS FL Auto transmitted light 
imaging system (Life Technologies) (Figure 6). DPSCs were detached using a mixture of 
phosphate-buffered saline (PBS) with 0.25% trypsin/0.5mM EDTA and placed with fresh 
growth media into sterile well plates under a biosafety cabinet (Figure 7).  
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Figure 6: Cell counting to verify ideal concentration of DPSCs for cell 
proliferation testing 
 
 
 
Figure 7: Detachment process of DPSCs using PBS with 0.25% 
trypsin/0.5mM EDTA 
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Experimental chitosan/CD hydrogels were exposed to UV radiation for 60 
minutes for disinfection. 0.15 g of each sample were loaded, in triplicate, into porous 
inserts and submerged into the well plates containing DPSCs. The porous inserts 
provided a means for diffusion across the insert/media interface while minimizing 
material washout. A positive control was maintained to demonstrate cell proliferation 
solely within media, containing empty inserts with no gel. Sample well plates were 
incubated at 37°C and removed for testing at intervals of 1, 2, 5, and 14 days. At each of 
these intervals, the following steps took place: 
1) Porous inserts and media were transferred to other wells (Figures 8, 9) 
2) 100 µl of PrestoBlue and 900 µl of DMEM were added to the cellular wells to 
establish a fluorescent marker and maintain cell health, respectively 
3) Cellular proliferation was evaluated using a Synergy HTX microplate reader 
(BioTek) to detect fluorescence, in triplicate of triplicated samples (Figure 10) 
4) DPSCs were transferred from the microplate back to their original wells, 
along with the corresponding media and inserts 
Every 3 days, half of the media was replaced with fresh media to maintain a healthy 
environment for cell growth while retaining the dissolved material that originated from 
the gel.  
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Figure 8: The transfer of inserts and media to new wells as part of the cell 
proliferation test protocol 
 
 
 
 
Figure 9: Porous inserts used in cell proliferation testing. Samples were loaded in 
the inserts and submerged in cell growth media 
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Figure 10: Synergy HTX microplate reader used to quantify cell proliferation 
 
 As a means for negative control comparisons, a supplemental experiment was 
performed using UltraCal XS Ca(OH)2 paste (Ultradent). Test groups were prepared by 
measuring paste amount by weight, using groups with 0.15 g, 0.1 g, 0.05 g, and 0 g 
(control) of the Ca(OH)2 paste. These samples were loaded, in triplicate, into the porous 
inserts using the cell proliferation protocol previously outlined (Figures 11, 12). Samples 
were tested at intervals of 1, 2, 5, and 14 days using a microplate reader and results were 
recorded.  
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Figure 11: Porous inserts with media at 24-hour test period. Rows are arranged in 
triplicate groups as follows: group 1 - 0.15 g Ca(OH)2; group 2 - 0.10 g Ca(OH)2; 
group 3 - 0.05 g Ca(OH)2; group C - control without Ca(OH)2. It was noted that the 
growth media in groups containing Ca(OH)2 changed to a bright pink color. 
 
 
 
 
1 
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C 
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Figure 12: Wells containing DPSCs and PrestoBlue/DMEM at 24 hours. After removal 
of porous inserts and corresponding media outlined in Figure 11, PrestoBlue/DMEM 
solution was added to samples containing DPSCs. Group 1 - cells from wells with 0.15 g 
Ca(OH)2, group 2 – cells from wells with 0.10 g Ca(OH)2, group 3 – cells from wells with 
0.05 g Ca(OH)2, group C – cells from control wells without Ca(OH)2. Note: wells with 
fresh media were maintained around the perimeter to minimize evaporation. Each well 
with PrestoBlue was dispensed in triplicate into a microwell plate and placed in the 
Synergy HTX reader. 
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RESULTS 
 
 
Preliminary Study Data to Determine Gelation Temperature 
 
 
 As stated previously, initial rheometry tests were performed using both single-
frequency and multiple-frequency settings. This provided a means for comparison 
between rheometry settings to determine an accurate approach for further tests. In 
addition, a broad range of β-GP concentrations were evaluated to determine the amount 
needed in order to reach an ideal 𝑇𝑜𝑛𝑠𝑒𝑡.  
Single-frequency rheometry demonstrated that 1.5% w/v chitosan with 300 mg/ml 
β-GP contained an ideal 𝑇𝑜𝑛𝑠𝑒𝑡 within the target range (Figure 13). In order to objectively 
 
 
Figure 13: Single-frequency rheometric graph indicating the relative gelation 
temperatures of 1.5% w/v chitosan with various concentrations of β-GP. Note: gelation 
onset temperature (𝑇𝑜𝑛𝑠𝑒𝑡) is indicated in red text. The only formulation with 𝑇𝑜𝑛𝑠𝑒𝑡 
below 37°C contained 300 mg/ml β-GP. 
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estimate 𝑇𝑜𝑛𝑠𝑒𝑡, the steady slopes of complex shear viscosity in the sol phase were 
compared to those in the gel phase (Figure 14). The 𝑇𝑜𝑛𝑠𝑒𝑡 was determined by calculating 
the point of intersection with these two slopes.  
 
Figure 14: Diagram demonstrating the method for determining the 𝑻𝒐𝒏𝒔𝒆𝒕 for 
samples tested with single-frequency rheometry. The 𝑇𝑜𝑛𝑠𝑒𝑡 is determined by 
calculating the point of intersection between sol phase and gel phase slopes.  
 
 
Considering the line equation 𝑦 = 𝑚𝑥 + 𝑏, where 𝑚 is the slope and 𝑏 the y-intercept, 
the following mathematic reasoning was used to determine the gelation onset 
temperature: 
𝑇𝑜𝑛𝑠𝑒𝑡 =  | 
𝑏𝑔𝑒𝑙 − 𝑏𝑠𝑜𝑙
𝑚𝑔𝑒𝑙 − 𝑚𝑠𝑜𝑙
 | 
 
Using this formula, the 𝑇𝑜𝑛𝑠𝑒𝑡 for the optimized hydrogel was 34.6°C (Figure 15).  
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Figure 15: Gelation onset temperature for the optimized hydrogel 
using single-frequency rheometry. Intersecting slopes (yellow lines) 
indicate that 𝑇𝑜𝑛𝑠𝑒𝑡 = 34.6°C, as shown by the green indicator.  
 
 
The results from evaluating the optimized chitosan at multiple frequencies 
showed that the 𝑇𝑜𝑛𝑠𝑒𝑡 was approximately 32°C-33°C. This was found by plotting the 
tan(δ) at corresponding temperatures between 30°C and 37°C among 11 frequencies 
ranging from 1.0 Hz to 10.0 Hz. The 𝑇𝑜𝑛𝑠𝑒𝑡 was analyzed visually along a graph by 
determining the range at which most of the points intersect (Figure 16). 
 
Figure 16: Multiple-frequency rheometric graph indicating gelation 
temperature of 1.5% w/v chitosan with 300 mg/ml β-GP. 
𝑇𝑜𝑛𝑠𝑒𝑡 =  
34.6°C 
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In comparison of the two rheometer parameters (single vs multiple-frequency), 
both tests yielded comparable findings. Due to the simplicity of using single-frequency 
settings, it was determined to proceed with this method throughout the remainder of the 
study. 
Gelation Properties of Experimental Hydrogels 
 
 
Data was collected and plotted on each of the remaining samples. The addition of 
CDs had a negligible effect on the 𝑇𝑜𝑛𝑠𝑒𝑡 compared to that of the plain optimized 
chitosan. In concentrations of both 25 µg/ml CDs and 50 µg/ml CDs, the measured 𝑇𝑜𝑛𝑠𝑒𝑡 
was 34.7°C (Figure 17).  
    
Figure 17: Gelation onset temperature for the optimized hydrogel with the addition of 
25 µg/ml CDs and 50 µg/ml CDs. Intersecting slopes (yellow lines) indicate that 𝑇𝑜𝑛𝑠𝑒𝑡 
= 34.7°C for each sample, as shown by the green indicator. 
 
 Cell Proliferation of Experimental Hydrogels and Calcium Hydroxide 
 
 
 Results from the cell proliferation tests were recorded and graphed for visual 
interpretation. Since the trials for experimental hydrogels and Ca(OH)2 were performed 
separately, a method calculating percentage change was used to compare each sample to 
their control group (Table 3).  
𝑇𝑜𝑛𝑠𝑒𝑡 =  
34.7°C 
𝑇𝑜𝑛𝑠𝑒𝑡 =  
34.7°C 
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Table 3: Proliferation results for experimental gels and Ca(OH)2 
 
 
The experimental hydrogels exhibited a more favorable environment for cell 
proliferation. In general, all samples remained relatively unchanged between days 1 and 
2. As evidenced by Table 3, the material with the greatest overall proliferation was the 
plain optimized chitosan. Cells exposed to this gel proliferated early and rapidly. 
Between days 2 and 5, a 203% increase in fluorescence values was detected. These 
values increased an additional 108% between days 5 and 14. The gels containing CDs 
performed nearly as well, with steady percentage increases exceeding 100% at these 
same intervals. 
Day 1 Day 2 Day 5 Day 14
% Change 
Days 1 & 2
% Change 
Days 2 & 5
% Change
Days 5 & 14
Optimized Chitosan,
25µg/ml CDs
760.9 ± 39.6 886.3 ± 34.9 1802.4 ± 290.1 4666.8 ± 737.5 16% 103% 159%
Optimized Chitosan,
50µg/ml CDs
752.6 ± 33.2 950.1 ± 67.6 2018.2 ± 68.9 4747.1 ± 613.4 26% 112% 135%
Optimized Chitosan 818.6 ± 95.7 917.9 ± 26.2 2779.7 ± 216.7 5768.2 ± 1097.7 12% 203% 108%
Control
(No Gel)
924.8 ± 62.1 843.3 ± 52.9 3936.1 ± 75.5 5411.2 ± 122.2 -9% 367% 37%
Day 1 Day 2 Day 5 Day 14
% Change 
Days 1 & 2
% Change 
Days 2 & 5
% Change
Days 5 & 14
UltraCal XS
    0.15 g
527.7 ± 7.9 541.2 ± 7.0 517 ± 7.9 518 ± 4.8 3% -4% 0%
UltraCal XS
   0.10 g 
528.6 ± 4.6 536.3 ± 3.4 514.7 ± 0.6 518.2 ± 5.8 1% -4% 1%
UltraCal XS
    0.05g
529.9 ± 2.4 538.6 ± 6.3 520.7 ± 0.6 550.3 ± 34.3 2% -3% 6%
  Control
(No Paste)
783.3 ± 28.4 854.1 ± 31.0 1721.6 ± 136.5 1296 ± 64.0 9% 102% -25%
Experimental Gels
Calcium Hydroxide
Mean Fluorescence of Triplicated Samples and Percent Change
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Figure 18: Cell proliferation results for the experimental gels. Recorded data points 
are based off fluorescence readings of cellular interaction with PrestoBlue. Error bars 
are indicative of the standard deviation of the gel samples. 
 
 
 
Figure 19: Cell proliferation results for UltraCal XS Ca(OH)2 paste. Recorded data 
points are based off fluorescence readings of cellular interaction with PrestoBlue. 
Error bars are indicative of the standard deviation of each group. 
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In each Ca(OH)2 sample, results showed little or no proliferation of DPSCs at 
each of the tested intervals (Figure 18). Between days 1 and 2, the percentage increase in 
proliferation was 1-3%. Each sample decreased in proliferation by 3-4% from days 2 to 5. 
At the final two time intervals (day 5 to 14), cell proliferation remained low at 0-6%. 
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DISCUSSION 
 
 
Ca(OH)2 and TAP have long been used as medicaments in endodontics. These 
materials, however, have some disadvantages that were previously discussed. In short, 
such drawbacks include pathogen resistance, tight adherence to dentin, and/or 
cytotoxicity concerns (35, 36, 39-42, 50). Though TAP is often regarded as cytotoxic to 
stem cells, there is no consensus on cytotoxicity with Ca(OH)2 (43-45).  
In all tested concentrations, Ca(OH)2 drastically suppressed cell proliferation 
throughout the 14-day test period. This indicates that Ca(OH)2 paste possesses a potent 
and long-lasting inhibitory effect on DPSCs. As it relates to regenerative endodontics 
(when proliferation of stem cells is paramount), these qualities are seemingly detrimental. 
Chitosan hydrogels could provide a vehicle for disinfection within the canal space that is 
“more kind” to stem cells, creating a potential for improved healing outcomes. 
There is a reasonable explanation for the claims made by some researchers that 
Ca(OH)2 is non-toxic, considering this study shows the contrary. To our knowledge, this 
study is the first to evaluate cell proliferation with Ca(OH)2 using porous inserts. When 
testing proliferation, this method provides a more realistic representation of testing the 
impact of the paste on stem cell growth over time. Porous inserts facilitate indirect 
contact of Ca(OH)2 with the cells via diffusion through media. At each tested interval, 
there is little risk of removing the original paste. This model simulates a single 
administration of Ca(OH)2 paste, similar to the manner in which it is delivered in most 
clinical applications. Additionally, the inserts allow for consistent evaluation at each test 
interval without disrupting the cell culture. This method seems more accurate than the 
common approach of mixing Ca(OH)2 powder into the growth media. 
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The positive control groups used in these proliferation tests demonstrated the 
growth pattern of DPSCs without the influence of a test gel or paste. It is noteworthy to 
address the phenomenon that cell growth was hindered between days 5 and 14 within 
each control group. This is likely due to cells reaching confluency within their respective 
well plates. Cells require room to proliferate and the population is negatively impacted 
without adequate space for expansion.  
Within each control group, cell counts increased most rapidly between days 2 and 
5. Throughout this same time period, the optimized chitosan group promoted exceptional 
proliferation. Based upon the findings presented in this study, this formulation seems to 
be the most biocompatible of all those tested. When CDs are added to the optimized 
injectable chitosan, cellular growth may be slightly lessened. This limitation seems 
minimal in comparison to the drastic inhibition presented by Ca(OH)2.  
In this study, CDs were functionalized with spermidine. The results presented 
indicate that this combination is relatively biocompatible when incorporated into a 
chitosan gel. Without further testing, it is difficult to quantify the proper therapeutic 
concentrations for endodontic use, as well as the factors that contribute to the slight 
decrease in cell proliferation. Given that CDs are inherently biocompatible (99, 100), it is 
logical that the level of cytotoxicity is more related to the functionalized surface than the 
CD nanoparticles themselves.  
The use of CDs for dental purposes is exciting and warrants continued study. CDs 
are incredibly versatile nanoparticles, containing a peripheral surface that can be 
functionalized with countless surface schemes. Previous researchers have outlined the 
benefits of conjugating antibiotics with the CD surface, including prolonged drug release 
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and enhanced efficacy (90, 101). Future experimentation may explore a wider spectrum 
of functional surface groups, particularly antibiotics and antibacterial agents. 
This study also demonstrates that chitosan hydrogels, with or without carbon dots, 
can be optimized to a specific 𝑇𝑜𝑛𝑠𝑒𝑡. Creating a hydrogel with a 𝑇𝑜𝑛𝑠𝑒𝑡 between 30°C 
and 37°C has promising implications, particularly for biomedical use. In concept, this 
would allow for the hydrogel to be injected into the human body in an aqueous sol phase, 
then undergo a transition to a more rigid and stable gel at body temperature. As this 
applies to endodontics, it is thought that such a hydrogel could function as a means for 
medicament delivery that resists washout.  
Within the limitations of this study, many attributes of this novel material have 
not been investigated. The antibacterial properties of each prepared hydrogel are still 
unknown. Previous authors have found that chitosan, as well as spermidine-
functionalized carbon dots, possess inherent antibacterial qualities (59, 60, 102). Though 
untested in this study, it is logical that the hydrogel formulations would perform 
favorably against bacterial and fungal pathogens. Antibacterial and antifungal tests could 
more definitively determine how these materials interact with such pathogens and 
indicate whether other chemical additives should be considered.  
Further studies could also enhance what is known about the physical properties of 
the optimized chitosan hydrogel. Factors such as dimensional stability over time, 
thermoreversibility, and shelf life are still unknown. Despite these untested material 
attributes, the formulated chitosan hydrogels presented in this study possess qualities that 
are particularly exciting and should be studied in greater detail. 
  
32 
CONCLUSION 
 
 
Chitosan/CD hydrogels may be a promising medicament for endodontic use and a 
viable alternative to either Ca(OH)2 or TAP in regenerative endodontic cases. The CD 
structure contains surface characteristics that are open to customization for individual 
therapeutic needs. This hydrogel is thermally responsive and becomes a solid gel when 
administered at human body temperature. Further studies are warranted to determine its 
antibacterial properties, as well as other factors to understand how it may interact in the 
root canal space.  
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